Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 75% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
Compare CURE with another fund →SYRE
SPYRE THERAPEUTI
Health Care · United States · 1.33% of CURE on average
Contributed −$18 per $10k to CURE over the last month.
Loading…
Explained moves, and what each did to CURE
About CURE
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 75%
- Top 2 holdings4%
CURE fell 4.7% over the last month. On $10,000, that's −$472. QURE was the biggest drag at −$46; MRNA helped most at +$93.
What moved it
Gain or loss per $10k invested
- MRNAModerna+$93
- GRALGrail+$63
- IOVAIovance+$55
- QUREUniqure−$46
- TWSTTwist+$36
- PRAXPraxis−$36
- ARWRArrowhead−$36
- DNTHDianthus−$34
- SRRKScholar Rock−$30
- TVTXTravere−$30
- NTRANatera+$29
- CELCCelcuity−$28
- INSMInsmed−$27
- ORKAOruka−$27
- ROIVRoivant−$25
- SLSSellas Life−$22
- CYTKCytokinetics−$22
- BMRNBiomarin−$22
- VKTXViking−$21
- MIRMMirum−$20
- IMVTImmunovant−$20
- IONSIonis Pharma−$19
- IBRXImmunitybio+$19
- SYRESpyre−$18
- NKTRNektar−$18
- CRSPCrispr−$14
- INCYIncyte−$13
- RVMDRevolution−$13
- REGNRegeneron−$12
- ABBVAbbVie+$11
- KRYSKrystal−$8
- KYMRKymera−$7
- TGTXTg Thera.−$7
- VRTXVertex Pharma−$6
- PTGXProtagonist−$6
- AMGNAmgen+$5
- EXELExelixis+$4
- BIIBBiogen+$3
- HALOHalozyme+$2
- GILDGilead+$0
- CurrencyForeign currencies against the Australian dollar+$261
- UnattributedHedging, fees, timing−$267
- CompoundingDaily returns multiply, they do not add−$20
- Fund return−$472
- Other 8 kinds of news−$9
- Other 6 kinds of news−$2
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.